Cargando…
Structure based drug designing of a novel antiflaviviral inhibitor for nonstructural 3 protein
Literature shows that Flaviviruses cause a variety of diseases, including fevers, encephalitis, and hemorrhagic fevers. NS3 is a multifunctional protein with an Nterminal protease domain (NS3pro) that is responsible for proteolytic processing of the viral polyprotein, and a C-terminal region that co...
Autores principales: | Jitendra, Singh, Vinay, Randhawa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082862/ https://www.ncbi.nlm.nih.gov/pubmed/21544165 |
Ejemplares similares
-
A comprehensive molecular interaction map for Hepatitis B virus and drug designing of a novel inhibitor for Hepatitis B X protein
por: Jitendra, Singh, et al.
Publicado: (2011) -
Structurebased drug design and AutoDock study of potential protein tyrosine kinase inhibitors.
por: Ali, Hamed Ismail, et al.
Publicado: (2011) -
Selection of an improved HDAC8 inhibitor through structure-based drug design
por: Vijayakumar, Balakrishnan, et al.
Publicado: (2011) -
Designing of Protein Kinase C β-II Inhibitors against Diabetic complications: Structure Based Drug Design, Induced Fit docking and analysis of active site conformational changes
por: Vijayakumar, Balakrishnan, et al.
Publicado: (2012) -
Virtual screening using the ligand ZINC database for novel lipoxygenase-3 inhibitors
por: Monika,, et al.
Publicado: (2013)